Table 1 Clinicopathological variables for the patient cohort (n = 441)
From: Cyclin-dependent kinase 9 (CDK9) predicts recurrence in Middle Eastern epithelial ovarian cancer
n (%) | |
|---|---|
Age | |
Median | 50.3 |
Range | 17.0–90.0 |
Histopathology | |
High grade Serous | 233 (52.8) |
Low grade Serous | 83 (18.8) |
Mucinous | 64 (14.5) |
Endometrioid | 40 (9.1) |
Clear cell | 10 (2.3) |
Undifferentiated | 11 (2.5) |
Histological Grade | |
Grade 1 | 98 (22.2) |
Grade 2 | 152 (34.5) |
Grade 3 | 175 (39.7) |
Unknown | 16 (3.6) |
pT | |
T1 | 89 (20.2) |
T2 | 40 (9.1) |
T3 | 307 (69.6) |
Unknown | 5 (1.1) |
pN | |
N0 | 401 (90.9) |
N1 | 35 (8.0) |
Unknown | 5 (1.1) |
pM | |
M0 | 358 (81.2) |
M1 | 78 (17.7) |
Unknown | 5 (1.1) |
Stage | |
I | 88 (20.0) |
II | 26 (5.9) |
III | 244 (55.3) |
IV | 78 (17.7) |
Unknown | 5 (1.1) |
Recurrence | |
Yes | 145 (32.9) |
No | 296 (67.1) |